Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

104.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 922
Open 104.89
Bid (Size) 105.00 (300)
Ask (Size) 107.70 (100)
Prev. Close 104.89
Today's Range 104.89 - 104.89
52wk Range 61.23 - 105.11
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
Revenue jumped 48% to $481 million on record royalty growth. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From Halozyme Therapeutics’s Q2 Earnings Call
Halozyme Therapeutics delivered a notably positive second quarter, as evidenced by the strong market reaction and management’s attribution of outperformance ... 
Via StockStory
Topics Earnings Intellectual Property

Performance

YTD
+49.2%
+49.2%
1 Month
+36.1%
+36.1%
3 Month
+52.6%
+52.6%
6 Month
+30.3%
+30.3%
1 Year
+52.1%
+52.1%

More News

Read More
News headline image
HALO Q2 Deep Dive: Royalty Diversification and New Pipeline Drive Upgraded Guidance
Via StockStory
Halozyme Therapeutics (NASDAQ:HALO): A Value Stock Profile Offering Strong Profitability and a Low Forward P/E ↗
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO): A Deep Value Play Combining Strong Profitability with an Attractive 14.35 P/E ↗
Via Chartmill
Halozyme Therapeutics (NASDAQ:HALO) Surges After Q1 Beat, Launches $1 Billion Buyback ↗
Via Chartmill
News headline image
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock to Research Further and 2 We Ignore
Via StockStory
News headline image
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales
Via StockStory
News headline image
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
Via StockStory
News headline image
3 Growth Stocks Set to Flourish
Via StockStory
News headline image
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
Via StockStory
Topics Energy
News headline image
1 Value Stock Worth Investigating and 2 Facing Headwinds
Via StockStory
News headline image
2 Reasons to Like HALO and 1 to Stay Skeptical
Via StockStory
Topics Stocks
News headline image
1 Surging Stock for Long-Term Investors and 2 We Brush Off
Via StockStory
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Question
Via StockStory
Topics Credit Cards
News headline image
Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today
Via StockStory
Topics Economy
News headline image
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings
News headline image
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)
Via StockStory
Topics Artificial Intelligence
News headline image
HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook
Via StockStory
News headline image
Halozyme (HALO) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Halozyme Therapeutics Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates
Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 104.89
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 08/18/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 14.93B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 15B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.